Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
22 people
Frazier Healthcare Partners
SeattleGrowth–Late Stage$50M – $400M
103 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Atlas Venture
CambridgeSeed–Series B$500K – $1M
84 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
99 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
29 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
Hellman & Friedman
San FranciscoGrowth–Late Stage
102 people
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
19 people
NC IDEA
DurhamPre-Seed–Seed
16 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
Baird Capital
ChicagoSeed–Growth
53 people
i5invest
San FranciscoSeed
70 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
62 people
Cerity Partners Ventures
New YorkSeed–Late Stage
61 people
WCAS
New YorkGrowth
91 people
Golden Seeds
FlushingPre-Seed–Series A$250K – $2M
60 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
60 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
74 people
Pillar VC
BostonPre-Seed–Series A$50K – $4M
62 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
TPG
San FranciscoGrowth–Late Stage
70 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.








































































































